Antidepressants and the risk of suicidal behaviors

JAMA

Volumn 292, Issue 3, 2004, Pages 338-343

  Jick, Hershel ^a   Kaye, James A ^a   Jick, Susan S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOSULEPIN; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ADRENERGIC RECEPTOR AFFECTING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE; CASE CONTROL STUDY; MIDDLE AGED; STATISTICS; SUICIDE ATTEMPT; UNITED KINGDOM;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHILD; DOTHIEPIN; FEMALE; FLUOXETINE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PAROXETINE; RISK; SEROTONIN UPTAKE INHIBITORS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 3142735110     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.3.338     Document Type: Article

References (11)

1. US Food and Drug Administration Psychopharmacological Drugs Advisory Committee Meeting, No. 34; September 20, 1991; Rockville, Md.
2. Beasley CM Jr, Dornself BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991;303:685-692.
3. Jick H, Ulcickas M, Dean A. Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone. Pharmacotherapy. 1992;12:451-454.
4. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995;310:215-218.
5. Interim Report of the Committee on Safety of Medicines' Expert Working Group on selective serotonin re-uptake inhibitors. Available at: http://www.mca.gov .uk/ourwork/monitorsafequalmed/safetymessages /ssriewginterimreportfinal.pdf. Accessed October 23, 2003.
6. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40:762-772.
7. Depressing research. Lancet. 2004;363:1335.
8. US Food and Drug Administration: FDA Talk Paper-FDA issues public health advisory entitled: reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD). Available at: http://www.fda .gov/bbs/topics/ANSWERS/2003/ANS01256 .html. Accessed October 28, 2003.
9. US Food and Drug Administration Public Health Advisory. Subject: Worsening depression and suicidality in patients being treated with antidepressant medications. Available at: http://www.fda.gov/cder/drug /antidepressants/AntidepressanstPHA.htm. Accessed May 7, 2004.
10. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. The validity of the General Practice Research Database. Pharmacotherapy. 2003;23:686-689.
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons; 2000.